Robert & Maggie Bras and Family New Drug Development Program
The Princess Margaret Hospital Foundation
The Bras Family Foundation

 

 

The Robert & Maggie Bras and Family New Drug Development Program came into being June 2002.  Robert Bras was being treated for Prostate and Gallbladder cancer at Princess Margaret, Toronto General and Toronto Western Hospital, all part of the University Health Network (UHN).  From time to time he received care at Mount Sinai Hospital.  Robert’s care was exemplary and the dedication of the doctors, nurses, clinicians, pharmacists and staff went beyond the call of duty.

Robert and I felt a desire to ‘give-back’.  We asked ourselves in what form this ‘giving back’ should take and after some consideration, we decided to create an endowment to help get on it’s feet, a drug development program at Princess Margaret Hospital.   Canada’s leading cancer centre is the only hospital exclusively devoted to the education, treatment and research of cancer.

Under the brilliant directorship of Dr. Malcolm Moore, along with co-directors, Drs. Amit Oza and Lillian Siu, The Robert & Maggie Bras and Family New Drug Development Program was on its feet with an amazing group of members all dedicated to fighting this insidious disease – cancer.  Our program is comprised of a multi-disciplinary team devoted to researching and developing new agents and therapies to eradicate cancer, primarily through early phase clinical trials.  The Bras Family Drug Development Program (BDDP), also works in concert with the Ontario Cancer Institute’s (OCI) drug discovery program to uncover biomarkers that will enable more targeted and effective drugs.

Funds contributed to the BDDP by our donors are used for the highest priorities – fellowship assistance, equipment, new facilities and technical support of clinical trials – that lead to new and improved treatments for cancer.  Thanks to our donors, we are one step closer to our vision.  To conquer cancer – IN OUR LIFETIME.

At present, the BDDP has an extremely large portfolio of Phase I and II studies which is gaining our centre both national and international recognition, securing our rank as one of the top five cancer research centres in the world.   And to top it all off, we have been named by three pharmaceuticals as the number one new drug development program in the world!

Since its inception, we have built a stunning new centre for our program within PMH, which is comprised of a 5400 square foot state of the art facility, with the very talented vision for our centre donated by renowned Toronto Interior Designer, Brian Gluckstein of Gluckstein Design along with his amazing staff.  Not only did Brian donate his vision, but companies and individuals within the  GTA donated artwork, accessories and handcrafted furniture.  Incredible generosity – thank you!

We have held five golf tournaments – The Robert Bras & Family Charity Golf  Tournament  at the awesome Summit Golf & Country Club, the last one taking place on July 9, 2007.  That year was a milestone for our tournament, as it was the fifth anniversary of Robert’s death, the fifth year of holding the tournament, and incredibly hitting our target of raising $500,000!  The day of the tournament saw us still shy of our goal by $15,000 and much to our amazement, an anonymous donor stepped forward with a cheque for the whole $15,000!  Thank you!

Over the years we have been truly blessed with a line up of guest speakers.  In 2006 our golfers listened to the brilliant Dr. Tak Mak , Director of the Campbell Family Breast Institute.  In 2007 we listened to our dedicated and talented Dr. Robert Bell, President and CEO of the University Health Network.  In 2008 we were to have as our guest speaker, Dr. Ben Neel, Director of the Ontario Cancer Institute.  Dr. Neel is an internationally recognized cancer researcher in cellular biology and is committed to translating cancer research into improved clinical care.  I have not listed all of our speakers, but do know that the information you have so generously imparted to our golfers and volunteers, have made an impact on our lives.  Thank you for taking the time away from your incredible careers.

Our challenge is to continue to improve treatment for cancer.  Our success is measured not only by the quality and rigor of our work, but also the impact we have on patients and their families.  The program continues to succeed because of the dedication and enthusiasm of our entire team toward the goal of providing longer and better lives for cancer patients.

We would be pleased to have you as our partners – to CONQUER CANCER – IN OUR LIFETIME!

Sincerely,

Maggie Bras

Maggie Bras
President, Advisory Committee

for information on Princess Margaret Hospital visit www.pmhf.ca; and
www.pmhf-uhn.ca/Pages/DonorImpact/Drug_Development_Landing.aspx
for an excellent summary of the program, also please tune in to the rest of our website.

Latest News:

The Ride to Conquer Cancer

The first annual Ride to Conquer Cancer held June 21st and 22nd of this year, had 2,850 riders depart the CNE in Toronto and ride over 2 days to Niagara Falls.  Over 100 km a day was covered by the riders for a total of 120 kilometers!  Nearly 125 doctors and researchers from across Princess Margaret participated in the ride.


GREETINGS FROM THE MAYOR OF MISSISSAUGA

Orison Swett Marden once said, "there is no medicine like hope, no incentive so great, and no tonic so powerful as expectation of something better tomorrow", and hope is exactly what the Robert and Maggie Bras and Family New Drug Development Program offers to patients who are suffering from cancer.


Paul Alofs, "Helping Hands" newsletter

Princess Margaret Hospital’s ambition is to be a world leader and to be recognized as one of the top 5 comprehensive cancer centres in the world. When I observe the work being done in the Robert & Maggie Bras New Drug Development Program and witness the treatment and care given to our patients, this ambition is evident. This same ambition provides clarity to our work and sets the bar for excellence.


The Robert Bras Memorial Lecture

Dr. Joseph Pater, Director, National Cancer Institute of Canada Clinical Trials Group, Vancouver, March 3, 2007.

Each year an international leader in cancer research gives The Robert Bras Memorial Lecture.  This year the lecture was included as part of the 3rd Princess Margaret Strategic Directions in Drug Development meeting that was held in Vancouver, British Columbia.  The lecture was given by Dr. Joseph Pater, Director of the National Cancer Institute of Canada Clinical Trials Group who is retiring after 25 years as head of NCIC.CTG and has been instrumental in making Canada a world leader in cancer research. 


Our Team: Featured Profiles
Dr. Amit Oza, Senior Staff Physician and Associate Professor of Medicine at Princess Margaret Hospital, University of Toronto is featured on "Our Team" page. Please visit this page for more information.
Home PageSearchPrinter-friendly version
 2008 Robert & Maggie Bras and Family New Drug Development Program